However, previously we were able to show that treatment with GM-CSF neutralizing antibodies almost abrogated tumor invasion in OTCs of a highly GM-CSF expressing HNSCC cell line (HNO97) 16 and can now demonstrate that this is associated with a decreased secretion of MMP-9 (Fig. 3F). This evidence concerns the gene MMP9 and head and neck squamous cell carcinoma.